News | Updated Endometriosis Clinical Guideline Focuses on Diagnosis, Treatment, and Recurrence Management
Scientists from University College London (UCL) and University College London Hospitals (UCLH), working with the European Society of Human Reproduction and Embryology (ESHRE), have introduced a new clinical guideline for endometriosis. It offers new hope to millions of women worldwide living with this chronic condition, severe pelvic pain, and reduced fertility.
Formally published by ESHRE, the guideline contains 109 updated evidence-based recommendations covering diagnosis; treatment of pain and infertility; recurrence management; special considerations for adolescents and postmenopausal patients; asymptomatic and extrapelvic disease; prevention; and cancer-related risks. Experts say it may significantly improve patients’ physical, mental, and social well-being, support clinical decision-making, and give patients a reliable tool for participating in treatment.
Professor Ertan Saridogan of the UCL Elizabeth Garrett Anderson Institute for Women's Health and UCLH Women’s Health has been deeply involved in ESHRE guideline development since 2003. He said: “The new guideline means more comprehensive support and care for people with endometriosis. This update pays particular attention to evidence involving adolescents and postmenopausal patients, proposes improvements to diagnosis, challenges the traditional use of laparoscopy and histopathology as the gold standard, and evaluates surgical, medical, and non-medical treatments together.”
The guideline took two years to develop. Professor Christian Becker, Director of the Endometriosis CaRe Centre in the University of Oxford’s Nuffield Department of Women’s and Reproductive Health, chaired the group, while ESHRE senior research specialist Dr. Nathalie Vermeulen led the research strategy. The team included pain specialists Dr. Katrine Petersen and Dr. Julia Cambitzi, medical and epidemiology experts from several European countries, and patient representatives.
Professor Becker said: “Endometriosis is extremely common yet has long been overlooked, often placing a heavy burden on patients and their families. We hope this guideline will help patients and clinicians better understand the disease and optimize treatment strategies.”
Kathleen King, an Irish endometriosis advocate and patient representative on the guideline group, added: “The guideline is the result of joint work by healthcare professionals and patient representatives. It will be an important communication tool for patients and doctors and help align care with evidence-based medicine and best practice. We encourage all patients and healthcare professionals to make full use of it.”
The ESHRE guideline reflects recent European advances in endometriosis research and management and provides an important global reference for early recognition, standardized treatment, and patient self-advocacy.
News | Updated Endometriosis Clinical Guideline Focuses on Diagnosis, Treatment, and Recurrence Management
News | Updated Endometriosis Clinical Guideline Focuses on Diagnosis, Treatment, and Recurrence Management
Scientists from University College London (UCL) and University College London Hospitals (UCLH), working with the European Society of Human Reproduction and Embryology (ESHRE), have introduced a new clinical guideline for endometriosis. It offers new hope to millions of women worldwide living with this chronic condition, severe pelvic pain, and reduced fertility.
Formally published by ESHRE, the guideline contains 109 updated evidence-based recommendations covering diagnosis; treatment of pain and infertility; recurrence management; special considerations for adolescents and postmenopausal patients; asymptomatic and extrapelvic disease; prevention; and cancer-related risks. Experts say it may significantly improve patients’ physical, mental, and social well-being, support clinical decision-making, and give patients a reliable tool for participating in treatment.
Professor Ertan Saridogan of the UCL Elizabeth Garrett Anderson Institute for Women's Health and UCLH Women’s Health has been deeply involved in ESHRE guideline development since 2003. He said: “The new guideline means more comprehensive support and care for people with endometriosis. This update pays particular attention to evidence involving adolescents and postmenopausal patients, proposes improvements to diagnosis, challenges the traditional use of laparoscopy and histopathology as the gold standard, and evaluates surgical, medical, and non-medical treatments together.”
The guideline took two years to develop. Professor Christian Becker, Director of the Endometriosis CaRe Centre in the University of Oxford’s Nuffield Department of Women’s and Reproductive Health, chaired the group, while ESHRE senior research specialist Dr. Nathalie Vermeulen led the research strategy. The team included pain specialists Dr. Katrine Petersen and Dr. Julia Cambitzi, medical and epidemiology experts from several European countries, and patient representatives.
Professor Becker said: “Endometriosis is extremely common yet has long been overlooked, often placing a heavy burden on patients and their families. We hope this guideline will help patients and clinicians better understand the disease and optimize treatment strategies.”
Kathleen King, an Irish endometriosis advocate and patient representative on the guideline group, added: “The guideline is the result of joint work by healthcare professionals and patient representatives. It will be an important communication tool for patients and doctors and help align care with evidence-based medicine and best practice. We encourage all patients and healthcare professionals to make full use of it.”
The ESHRE guideline reflects recent European advances in endometriosis research and management and provides an important global reference for early recognition, standardized treatment, and patient self-advocacy.
Source:
Collected online